- Medtronic is set to acquire Nutrino of Health & # 39; Israel, provider & # 39; Data analytics nutrition, to strengthen its offerings diabetes group. The financial terms of the deal were not disclosed by the companies.
- The company & # 39; medical device intends to integrate the capabilities of & # 39; analysis & # 39; food & # 39; Nutrino with its own device to treat diabetes to help patients better manage their condition. The services & # 39; Nutrino include tools & # 39; artificial intelligence to personalized analysis & # 39; as nutritional intake affects the health of & # 39; person.
- When closing the transaction by the end of Q3, Medtronic will acquire a database on food & # 39; Nutrino, system & # 39; food analysis and expert knowledge about nutrition science.
Medtronic is a leader in the industry to develop technologies for diabetes management, which built the first hybrid system & # 39; closed cycle approved by the FDA to continuously monitor z blood sugar and administer doses & # 39 ; insulin, known as the "artificial pancreas".
With the acquisition of & # 39; Nutrino, Medtronic aims to help simplify the management of food and nutrition for patients with diabetes. Nutrino developed algorithms to predict the glycemic responses to foods. Medtronic is seeking to integrate that technology with continuous glucose monitoring (CGM) and & # 39; & # 39 distribution systems; Insulin b & # 39; closed loop.
In Q2 profit reported in the last week, the income of the diabetes group reached 26.2%, mainly on the sales pump system & # 39; insulin b & # 39; MiniMed closed circuit 670G and ongoing system & # 39; glucose monitoring Guardian Connect.
Medtronic and Nutrino began working together in & # 39; June 2016, and Nutrino played a role in the recent introductions & # 39; US products from Medtronic, the companies said. Those include updated app iPro2 myLog used by & # 39; Professional CGM devices and the Sugar.IQ diabetes Assistant Applicant used with the CGM system & # 39; Guardian Smart Connect.
The application uses analytical Sugar.IQ & # 39; IBM Watson to find patterns in the data on glucose and offer feedback in & # 39; real-time and personalized dosages based on & # 39; insulin & # 39; & # 39 making; food & # 39; patient, routines & # 39; day and other factors.
The myLog iPro2 application allows the doctor to evaluate the meals & # 39; patient based on individual glucose response. The activity log & # 39; patients and glucose readings, and take pictures & # 39; each meal and snack to eat their food. The platform generates Pattern Snapshot showing time in glucose target range, model & # 39; variability of glucose and graph the complete tracing of glucose. Second report called FoodPrint produce scores (A, B, C, D or F) for each meal based on the reaction of the body glucose.
"The collection & # 39; Nutrino and expertise nutrition in our organization gives us substantial differentiation in diabetes industry and move our progress in helping people with & # 39; diabetes live b & # 39; a lot of freedom and better health ", said Hooman Hakam, president of the Diabetes Group at Medtronic.
The acquisition is expected to close in the third fiscal quarter & # 39; Medtronic ending 25 & # 39; Expected in January 2019. The transaction is neutral to profit share in fiscal year 2019 share.